Immunotherapy in head and neck cancer: where do we stand?
NG Vallianou, A Evangelopoulos, D Kounatidis… - Current Oncology …, 2023 - Springer
Abstract Purposeof Review Head and neck cancer (HNC) comprises a group of
malignancies, amongst which squamous cell carcinoma accounts for more than 90% of the …
malignancies, amongst which squamous cell carcinoma accounts for more than 90% of the …
Targeting PI3K/AKT/mTOR signaling pathway as a radiosensitization in head and neck squamous cell carcinomas
YC Su, WC Lee, CC Wang, SA Yeh, WH Chen… - International Journal of …, 2022 - mdpi.com
Globally, there are over half a million new patients with head and neck squamous cell
carcinomas (HNSCC) every year. The current therapeutic approaches to HNSCC are …
carcinomas (HNSCC) every year. The current therapeutic approaches to HNSCC are …
Advantages of the combinatorial molecular targeted therapy of head and neck cancer—A step before anakoinosis-based personalized treatment
R Kleszcz - Cancers, 2023 - mdpi.com
Simple Summary Head and Neck Squamous Cell Carcinoma (HNSCC) is a major threat to
public health around the world. Its occurrence is linked to genetic events and environmental …
public health around the world. Its occurrence is linked to genetic events and environmental …
Prevalence of locoregional recurrence and survival post-treatment of head and neck cancers in Africa: a systematic review and meta-analysis
H Melariri, T Els, O Oyedele, TK Suttle… - …, 2023 - thelancet.com
Background Recurrent cancers of the head and neck are associated with poor survival
outcome. Yet, their burden in Africa is not reliably known. We therefore aimed to estimate the …
outcome. Yet, their burden in Africa is not reliably known. We therefore aimed to estimate the …
Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy
Objectives The aim of this pilot study is to identify the genetic factors that contribute to the
response of metronomic chemotherapy in head and neck squamous cell carcinoma …
response of metronomic chemotherapy in head and neck squamous cell carcinoma …
Recent advances in head and neck surgical oncology
In recent years, the field of head and neck oncology has witnessed a remarkable
transformation with unprecedented advances that have revolutionized the management of …
transformation with unprecedented advances that have revolutionized the management of …
[HTML][HTML] Molecular pathways and targeted therapies in head and neck cancers pathogenesis
M Constantin, MC Chifiriuc, C Bleotu… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
The substantial heterogeneity exhibited by head and neck cancer (HNC), encompassing
diverse cellular origins, anatomical locations, and etiological contributors, combined with the …
diverse cellular origins, anatomical locations, and etiological contributors, combined with the …
[HTML][HTML] Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications
Abstract Cutaneous Squamous Cell Carcinoma (cSCC) is a common and potentially fatal
type of skin cancer that poses a significant threat to public health and has a high prevalence …
type of skin cancer that poses a significant threat to public health and has a high prevalence …
Exploring the frontiers: tumor immune microenvironment and immunotherapy in head and neck squamous cell carcinoma
S Liu, R Wang, J Fang - Discover Oncology, 2024 - Springer
The global prevalence of head and neck malignancies positions them as the sixth most
common form of cancer, with the head and neck squamous cell carcinoma (HNSCC) …
common form of cancer, with the head and neck squamous cell carcinoma (HNSCC) …
Machine learning developed a macrophage signature for predicting prognosis, immune infiltration and immunotherapy features in head and neck squamous cell …
Y Wang, YK Mou, WC Liu, HR Wang, XY Song… - Scientific Reports, 2024 - nature.com
Macrophages played an important role in the progression and treatment of head and neck
squamous cell carcinoma (HNSCC). We employed weighted gene co-expression network …
squamous cell carcinoma (HNSCC). We employed weighted gene co-expression network …